INOpulse

July 30, 2015November 5, 2015

Bellerophon Adds New Cardiopulmonary Indications for INOpulse System in New Licensing Agreement

Clinical stage biotherapeutics company Bellerophon Therapeutics recently took steps to expand its licensing agreement with INO Therapeutics LLC, a subsidiary of Mallinckrodt plc, which allows Bellerophon to advance INOpulse as a ... Read more

May 8, 2015November 5, 2015

Bellerophon’s New Scientific Board to Focus on PH Device

News, Pulmonary Hypertension

Bellerophon Therapeutics, Inc. has established a new INOpulse Scientific Advisory Board (SAB) to help develop its proprietary novel technology to treat pulmonary hypertension (PH). The board includes internationally recognized specialists in the disease ... Read more